{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:49:50Z","timestamp":1783763390033,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400052C"],"award-info":[{"award-number":["HHSN272201400052C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00044"],"award-info":[{"award-number":["75N93019C00044"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66878-3","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:36:26Z","timestamp":1764808586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Discovery of a small molecule TLR3 agonist adjuvant"],"prefix":"10.1038","volume":"17","author":[{"given":"Branden","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2180-6508","authenticated-orcid":false,"given":"Danica","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Nanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-1847","authenticated-orcid":false,"given":"John Mark","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia Z.","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshine","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Borriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-2125","authenticated-orcid":false,"given":"Soumik","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3184-8285","authenticated-orcid":false,"given":"Byron","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-3752","authenticated-orcid":false,"given":"Manisha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Marques-Mourlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2680-1555","authenticated-orcid":false,"given":"Maansi V.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Lister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiwoo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lyskawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Ki","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer E.","family":"Brightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-5167","authenticated-orcid":false,"given":"Timothy R.","family":"O\u2019Meara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ryff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cali","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3648-9461","authenticated-orcid":false,"given":"Sanya","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1791-0161","authenticated-orcid":false,"given":"Simon D.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Pettengill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-2102","authenticated-orcid":false,"given":"Hyuk-Soo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-5929","authenticated-orcid":false,"given":"Sirano","family":"Dhe-Paganon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6097-2763","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5859-1945","authenticated-orcid":false,"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1095-6156","authenticated-orcid":false,"given":"David J.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"66878_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499\u2013511 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"66878_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s42003-024-06390-4","volume":"7","author":"SS Sch\u00fcller","year":"2024","unstructured":"Sch\u00fcller, S. S. et al. Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro. Commun. Biol. 7, 709 (2024).","journal-title":"Commun. Biol."},{"key":"66878_CR3","doi-asserted-by":"publisher","unstructured":"Lee, B., Nanishi, E., Levy, O. & Dowling, D. J. Precision vaccinology approaches for the development of adjuvanted vaccines targeted to distinct vulnerable populations. Pharmaceutics 15 https:\/\/doi.org\/10.3390\/pharmaceutics15061766 (2023).","DOI":"10.3390\/pharmaceutics15061766"},{"key":"66878_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/1757913916641586","volume":"136","author":"DJ Dowling","year":"2016","unstructured":"Dowling, D. J. Early life immune ontogeny\u2014understanding how we build and sustain immunity to infection. Perspect. Public Health 136, 205\u2013207 (2016).","journal-title":"Perspect. Public Health"},{"key":"66878_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.coi.2012.11.001","volume":"25","author":"SY Zhang","year":"2013","unstructured":"Zhang, S. Y. et al. TLR3 immunity to infection in mice and humans. Curr. Opin. Immunol. 25, 19\u201333 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"66878_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"A Iwasaki","year":"2004","unstructured":"Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987\u2013995 (2004).","journal-title":"Nat. Immunol."},{"key":"66878_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1073\/pnas.95.2.588","volume":"95","author":"FL Rock","year":"1998","unstructured":"Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A. & Bazan, J. F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95, 588\u2013593 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66878_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 5, 461 (2014).","journal-title":"Front. Immunol."},{"key":"66878_CR9","doi-asserted-by":"publisher","first-page":"20446","DOI":"10.1073\/pnas.0810372105","volume":"105","author":"H Negishi","year":"2008","unstructured":"Negishi, H. et al. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA 105, 20446\u201320451 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66878_CR10","doi-asserted-by":"publisher","first-page":"23208","DOI":"10.1074\/jbc.M109.047464","volume":"285","author":"C Gorbea","year":"2010","unstructured":"Gorbea, C. et al. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J. Biol. Chem. 285, 23208\u201323223 (2010).","journal-title":"J. Biol. Chem."},{"key":"66878_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001224","volume":"8","author":"H Sultan","year":"2020","unstructured":"Sultan, H. et al. Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration. J. Immunother. Cancer 8, e001224 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"66878_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1586\/14760584.2015.966085","volume":"14","author":"KAO Martins","year":"2015","unstructured":"Martins, K. A. O., Bavari, S. & Salazar, A. M. Vaccine adjuvant uses of poly-IC and derivatives. Expert Rev. Vaccines 14, 447\u2013459 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"66878_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12026-021-09203-6","volume":"69","author":"A Komal","year":"2021","unstructured":"Komal, A., Noreen, M. & El-Kott, A. F. TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review. Immunologic Res. 69, 312\u2013322 (2021).","journal-title":"Immunologic Res."},{"key":"66878_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1075291","volume":"14","author":"KH Ko","year":"2023","unstructured":"Ko, K. H. et al. A novel defined TLR3 agonist as an effective vaccine adjuvant. Front. Immunol. 14, 1075291 (2023).","journal-title":"Front. Immunol."},{"key":"66878_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.22","volume":"5","author":"JK Dowling","year":"2016","unstructured":"Dowling, J. K. & Mansell, A. Toll-like receptors: the swiss army knife of immunity and vaccine development. Clin. Transl. Immunol. 5, e85 (2016).","journal-title":"Clin. Transl. Immunol."},{"key":"66878_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2165\/00002018-200023060-00001","volume":"23","author":"G Moyle","year":"2000","unstructured":"Moyle, G. Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism? Drug Saf. 23, 467\u2013481 (2000).","journal-title":"Drug Saf."},{"key":"66878_CR17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1084\/jem.20080091","volume":"205","author":"H Kato","year":"2008","unstructured":"Kato, H. et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205, 1601\u20131610 (2008).","journal-title":"J. Exp. Med."},{"key":"66878_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/57.3.599","volume":"57","author":"RA Robinson","year":"1976","unstructured":"Robinson, R. A. et al. A phase I\u2013II trial of multiple-dose polyriboinosinic-polyribocytidylic acid in patients with leukemia or solid tumors. J. Natl Cancer Inst. 57, 599\u2013602 (1976).","journal-title":"J. Natl Cancer Inst."},{"key":"66878_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","volume":"441","author":"H Kato","year":"2006","unstructured":"Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101\u2013105 (2006).","journal-title":"Nature"},{"key":"66878_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/283649","volume":"2013","author":"K Naumann","year":"2013","unstructured":"Naumann, K. et al. Activation of dendritic cells by the novel toll-like receptor 3 agonist RGC100. Clin. Developmental Immunol. 2013, 283649 (2013).","journal-title":"Clin. Developmental Immunol."},{"key":"66878_CR21","first-page":"11","volume":"11","author":"D Crommelin","year":"2005","unstructured":"Crommelin, D. et al. Pharmaceutical evaluation of biosimilars: important differences from generic low-molecular-weight pharmaceuticals. Eur. J. Hosp. Pharm. Sci. 11, 11\u201317 (2005).","journal-title":"Eur. J. Hosp. Pharm. Sci."},{"key":"66878_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2020.100075","volume":"9","author":"FD Makurvet","year":"2021","unstructured":"Makurvet, F. D. Biologics vs. small molecules: drug costs and patient access. Med. Drug Discov. 9, 100075 (2021).","journal-title":"Med. Drug Discov."},{"key":"66878_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1128\/IAI.00573-09","volume":"78","author":"DJ Dowling","year":"2010","unstructured":"Dowling, D. J. et al. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect. Immun. 78, 793\u2013801 (2010).","journal-title":"Infect. Immun."},{"key":"66878_CR24","doi-asserted-by":"publisher","first-page":"15319","DOI":"10.1074\/jbc.R700009200","volume":"282","author":"S Uematsu","year":"2007","unstructured":"Uematsu, S. & Akira, S. Toll-like receptors and type I interferons. J. Biol. Chem. 282, 15319\u201315323 (2007).","journal-title":"J. Biol. Chem."},{"key":"66878_CR25","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1021\/ja111312h","volume":"133","author":"K Cheng","year":"2011","unstructured":"Cheng, K., Wang, X. & Yin, H. Small-molecule inhibitors of the TLR3\/dsRNA complex. J. Am. Chem. Soc. 133, 3764\u20133767 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"66878_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MOP.0000000000000868","volume":"32","author":"E Nanishi","year":"2020","unstructured":"Nanishi, E., Dowling, D. J. & Levy, O. Toward precision adjuvants: optimizing science and safety. Curr. Opin. Pediatr. 32, 125\u2013138 (2020).","journal-title":"Curr. Opin. Pediatr."},{"key":"66878_CR27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran, B., S Arunachalam, P. & O'Hagan, D. T. Emerging concepts in the science of vaccine adjuvants. Nat. Rev. Drug Discov. 20, 454\u2013475 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"66878_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2020.101426","volume":"50","author":"DT O\u2019Hagan","year":"2020","unstructured":"O\u2019Hagan, D. T., Lodaya, R. N. & Lofano, G. The continued advance of vaccine adjuvants\u2014we can work it out. Semin. Immunol. 50, 101426 (2020).","journal-title":"Semin. Immunol."},{"key":"66878_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662218","volume":"12","author":"S Barman","year":"2021","unstructured":"Barman, S., Soni, D., Brook, B., Nanishi, E. & Dowling, D. J. Precision vaccine development: cues from natural immunity. Front Immunol. 12, 662218 (2021).","journal-title":"Front Immunol."},{"key":"66878_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/npjvaccines.2016.10","volume":"1","author":"E Bardel","year":"2016","unstructured":"Bardel, E. et al. Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection. npj Vaccines 1, 16010 (2016).","journal-title":"npj Vaccines"},{"key":"66878_CR31","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.4049\/jimmunol.177.11.7959","volume":"177","author":"V Flacher","year":"2006","unstructured":"Flacher, V. et al. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol. 177, 7959\u20137967 (2006).","journal-title":"J. Immunol."},{"key":"66878_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yadr.2008.09.004","volume":"24","author":"LS Miller","year":"2008","unstructured":"Miller, L. S. Toll-like receptors in skin. Adv. Dermatol. 24, 71\u201387 (2008).","journal-title":"Adv. Dermatol."},{"key":"66878_CR33","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.3107127","volume":"236","author":"CM Snapper","year":"1987","unstructured":"Snapper, C. M. & Paul, W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944\u2013947 (1987).","journal-title":"Science"},{"key":"66878_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham, A. L. et al. Efficacy of the Herpes Zoster subunit vaccine in adults 70 years of age or older. N. Engl. J. Med 375, 1019\u20131032 (2016).","journal-title":"N. Engl. J. Med"},{"key":"66878_CR35","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal, H. et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 372, 2087\u20132096 (2015).","journal-title":"N. Engl. J. Med."},{"key":"66878_CR36","doi-asserted-by":"publisher","unstructured":"Luchner, M., Reinke, S. & Milicic, A. TLR agonists as vaccine adjuvants targeting cancer and infectious diseases. Pharmaceutics 13 https:\/\/doi.org\/10.3390\/pharmaceutics13020142 (2021).","DOI":"10.3390\/pharmaceutics13020142"},{"key":"66878_CR37","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.4049\/jimmunol.175.5.3339","volume":"175","author":"HS Youn","year":"2005","unstructured":"Youn, H. S. et al. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175, 3339\u20133346 (2005).","journal-title":"J. Immunol."},{"key":"66878_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pharmthera.2009.06.012","volume":"124","author":"PM Barral","year":"2009","unstructured":"Barral, P. M. et al. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharm. Ther. 124, 219\u2013234 (2009).","journal-title":"Pharm. Ther."},{"key":"66878_CR39","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.4049\/jimmunol.1400840","volume":"195","author":"N Dauletbaev","year":"2015","unstructured":"Dauletbaev, N., Cammisano, M., Herscovitch, K. & Lands, L. C. Stimulation of the RIG-I\/MAVS pathway by polyinosinic:polycytidylic acid upregulates IFN-\u03b2 in airway epithelial cells with minimal costimulation of IL-8. J. Immunol. 195, 2829\u20132841 (2015).","journal-title":"J. Immunol."},{"key":"66878_CR40","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.cell.2022.01.009","volume":"185","author":"F Borriello","year":"2022","unstructured":"Borriello, F. et al. An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity. Cell 185, 614\u2013629 e621 (2022).","journal-title":"Cell"},{"key":"66878_CR41","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1021\/acs.jmedchem.7b00419","volume":"60","author":"L Zhang","year":"2017","unstructured":"Zhang, L., Dewan, V. & Yin, H. Discovery of small molecules as multi-toll-like receptor agonists with proinflammatory and anticancer activities. J. Med. Chem. 60, 5029\u20135044 (2017).","journal-title":"J. Med. Chem."},{"key":"66878_CR42","doi-asserted-by":"publisher","first-page":"16254","DOI":"10.1021\/acsomega.1c03011","volume":"6","author":"KN Ganesh","year":"2021","unstructured":"Ganesh, K. N. et al. Green chemistry: a framework for a sustainable future. ACS Omega 6, 16254\u201316258 (2021).","journal-title":"ACS Omega"},{"key":"66878_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41563-018-0256-5","volume":"18","author":"DS Wilson","year":"2019","unstructured":"Wilson, D. S. et al. Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity. Nat. Mater. 18, 175\u2013185 (2019).","journal-title":"Nat. Mater."},{"key":"66878_CR44","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/cns.12469","volume":"21","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. TLR3 ligand poly IC attenuates reactive astrogliosis and improves recovery of rats after focal cerebral ischemia. CNS Neurosci. Ther. 21, 905\u2013913 (2015).","journal-title":"CNS Neurosci. Ther."},{"key":"66878_CR45","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1073\/pnas.1018515108","volume":"108","author":"JE Cole","year":"2011","unstructured":"Cole, J. E. et al. Unexpected protective role for Toll-like receptor 3 in the arterial wall. Proc. Natl. Acad. Sci. USA 108, 2372\u20132377 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66878_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.stem.2015.07.008","volume":"17","author":"AM Nelson","year":"2015","unstructured":"Nelson, A. M. et al. dsRNA released by tissue damage activates TLR3 to drive skin regeneration. Cell Stem Cell 17, 139\u2013151 (2015).","journal-title":"Cell Stem Cell"},{"key":"66878_CR47","doi-asserted-by":"publisher","unstructured":"Zheng, X., Li, S. & Yang, H. Roles of toll-like receptor 3 in human tumors. Front. Immunol. 12 https:\/\/doi.org\/10.3389\/fimmu.2021.667454 (2021).","DOI":"10.3389\/fimmu.2021.667454"},{"key":"66878_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj5305","volume":"14","author":"E Nanishi","year":"2022","unstructured":"Nanishi, E. et al. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Sci. Transl. Med 14, eabj5305 (2022).","journal-title":"Sci. Transl. Med"},{"key":"66878_CR49","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.1128\/JVI.01410-12","volume":"86","author":"J Zhao","year":"2012","unstructured":"Zhao, J. et al. Intranasal treatment with poly(I\u2022C) protects aged mice from lethal respiratory virus infections. J. Virol. 86, 11416\u201311424 (2012).","journal-title":"J. Virol."},{"key":"66878_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31198-3","volume":"13","author":"D Horvath","year":"2023","unstructured":"Horvath, D. et al. Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim\u2122 elicits strong antibody and T-cell responses in mice. Sci. Rep. 13, 4648 (2023).","journal-title":"Sci. Rep."},{"key":"66878_CR51","doi-asserted-by":"publisher","first-page":"e98239","DOI":"10.1371\/journal.pone.0098239","volume":"9","author":"L Tengroth","year":"2014","unstructured":"Tengroth, L. et al. Functional effects of toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS ONE 9, e98239 (2014).","journal-title":"PLoS ONE"},{"key":"66878_CR52","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/INF.0000000000000893","volume":"34","author":"DJ Dowling","year":"2015","unstructured":"Dowling, D. J. & Levy, O. Pediatric vaccine adjuvants: components of the modern vaccinologist\u2019s toolbox.  Pediatr. Infect. Dis. J. 34, 1395\u20131398 (2015).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"66878_CR53","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41390-020-01112-y","volume":"89","author":"D Soni","year":"2021","unstructured":"Soni, D., Bobbala, S., Li, S., Scott, E. A. & Dowling, D. J. The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems. Pediatr. Res. 89, 1364\u20131372 (2021).","journal-title":"Pediatr. Res."},{"key":"66878_CR54","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3389\/fimmu.2017.01772","volume":"8","author":"F Borriello","year":"2017","unstructured":"Borriello, F. et al. Identification and characterization of stimulator of interferon genes as a robust adjuvant target for early life immunization. Front. Immunol. 8, 1772 (2017).","journal-title":"Front. Immunol."},{"key":"66878_CR55","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91020","volume":"2","author":"DJ Dowling","year":"2017","unstructured":"Dowling, D. J. et al. TLR7\/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight 2, e91020 (2017).","journal-title":"JCI Insight"},{"key":"66878_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4049\/immunohorizons.1700063","volume":"2","author":"DJ Dowling","year":"2018","unstructured":"Dowling, D. J. Recent advances in the discovery and delivery of TLR7\/8 agonists as vaccine adjuvants. ImmunoHorizons 2, 185\u2013197 (2018).","journal-title":"ImmunoHorizons"},{"key":"66878_CR57","doi-asserted-by":"crossref","unstructured":"Mir, M. A. in Developing Costimulatory Molecules for Immunotherapy of Diseases (ed Manzoor Ahmad Mir) 1\u201343 (Academic Press, 2015).","DOI":"10.1016\/B978-0-12-802585-7.00001-7"},{"key":"66878_CR58","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.4049\/jimmunol.172.5.2778","volume":"172","author":"Y Zheng","year":"2004","unstructured":"Zheng, Y. et al. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells1.  J. Immunol. 172, 2778\u20132784 (2004).","journal-title":"J. Immunol."},{"key":"66878_CR59","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1471-4906(03)00111-X","volume":"24","author":"DM Sansom","year":"2003","unstructured":"Sansom, D. M., Manzotti, C. N. & Zheng, Y. What\u2019s the difference between CD80 and CD86? Trends Immunol. 24, 314\u2013319 (2003).","journal-title":"Trends Immunol."},{"key":"66878_CR60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ebiom.2015.11.041","volume":"3","author":"KAO Martins","year":"2016","unstructured":"Martins, K. A. O. et al. Adjuvant-enhanced CD4 T Cell responses are critical to durable vaccine immunity. EBioMedicine 3, 67\u201378 (2016).","journal-title":"EBioMedicine"},{"key":"66878_CR61","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cyto.2007.11.020","volume":"41","author":"D Dowling","year":"2008","unstructured":"Dowling, D., Hamilton, C. M. & O\u2019Neill, S. M. A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine 41, 254\u2013262 (2008).","journal-title":"Cytokine"},{"key":"66878_CR62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni, L., Sen, N., Oliver, S. L. & Arvin, A. M. Molecular mechanisms of varicella zoster virus pathogenesis. Nat. Rev. Microbiol 12, 197\u2013210 (2014).","journal-title":"Nat. Rev. Microbiol"},{"key":"66878_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310886","volume":"36","author":"X Cheng","year":"2024","unstructured":"Cheng, X. et al. A synergistic lipid nanoparticle encapsulating mRNA Shingles vaccine induces potent immune responses and protects guinea pigs from viral challenges. Adv. Mater. 36, e2310886 (2024).","journal-title":"Adv. Mater."},{"key":"66878_CR64","doi-asserted-by":"publisher","first-page":"e1002367","DOI":"10.1371\/journal.ppat.1002367","volume":"7","author":"K Haberthur","year":"2011","unstructured":"Haberthur, K. et al. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection. PLoS Pathog. 7, e1002367 (2011).","journal-title":"PLoS Pathog."},{"key":"66878_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg3747","volume":"10","author":"D Soni","year":"2024","unstructured":"Soni, D. et al. From hit to vial: precision discovery and development of an imidazopyrimidine TLR7\/8 agonist adjuvant formulation. Sci. Adv. 10, eadg3747 (2024).","journal-title":"Sci. Adv."},{"key":"66878_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/cyto.a.24926","volume":"107","author":"S Barman","year":"2025","unstructured":"Barman, S. et al. OMIP-111: Immune-profiling of T helper 1 (Th1), Th2, and Th17 signatures in murine splenocytes by targeting intracellular cytokines. Cytom. A 107, 221\u2013225 (2025).","journal-title":"Cytom. A"},{"key":"66878_CR67","doi-asserted-by":"publisher","unstructured":"Koldehoff, M., Horn, P. A. & Lindemann, M. Cellular Immune response after vaccination with an adjuvanted, recombinant zoster vaccine in allogeneic hematopoietic stem cell transplant recipients. Vaccines 10 https:\/\/doi.org\/10.3390\/vaccines10050809 (2022).","DOI":"10.3390\/vaccines10050809"},{"key":"66878_CR68","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jaci.2016.12.985","volume":"140","author":"DJ Dowling","year":"2017","unstructured":"Dowling, D. J. et al. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses. J. Allergy Clin. Immunol. 140, 1339\u20131350 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"66878_CR69","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3389\/fimmu.2016.00562","volume":"7","author":"DJ Dowling","year":"2016","unstructured":"Dowling, D. J. et al. A meningococcal outer membrane vesicle vaccine incorporating genetically attenuated endotoxin dissociates inflammation from immunogenicity. Front. Immunol. 7, 562 (2016).","journal-title":"Front. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66878-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:15:33Z","timestamp":1768342533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66878-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66878"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66878-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.B., O.L., and D.J.D. are named inventors on patent applications held by Boston Children\u2019s Hospital related to thiazole benzamide compounds, including PVP-057, encompassing their use as immunomodulators and adjuvants. F.B., B.B., O.L., E.N., Y.S., T.R.O., S.D.v.H., and D.J.D. are named inventors on patent applications related to multiple adjuvants and vaccinal antigens. O.L. is a consultant to and his laboratory receives sponsored research support from\n                      GlaxoSmithKline\n                      (GSK). He also receives royalties from Wolters Kluwer for his contribution to a chapter in\n                      UpToDate\n                      . D.J.D. has served as a consultant for Merck Research Laboratories\/Merck Sharp & Dohme Corp. (a Merck & Co., Inc. subsidiary), is on EdJen BioTech\u2019s scientific advisory board, and his laboratory receives sponsored research support from Merck and Combined Therapeutics. O.L. and D.J.D. are co-founders of ARMR Sciences. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}